Where does Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA ranks #8,179 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA hold?

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA holds 39 US utility patents granted between 2015 and 2025, spanning 22 technology areas.

What is Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's Innovation Score?

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA has an Innovation Score of 40.9 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's patent grant rate increasing or decreasing?

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's patents?

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA

Q: What technology areas does Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA focus on?

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 31 patents, ranking #634 of 6,058 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

Q: How is the Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 39 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Centro ranks #8,179 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 22 technology areas.

#8,179
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 9.8
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8179 · Foreign Corporation #8,179 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 39 grants
UPPER-Q #8,179/49,997
PHOTO-FINISH Bedford Systems
CPC-FOCUS A61P · 22 areas
INNOV-PAR 40.9/100
CLAIMS-PAR 9.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bedford Systems LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Centro’s 40.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (31%) Velocity 5.7 pts (14%) Breadth 16.6 pts (41%) Claim depth 5.9 pts (14%)

Qualcomm Incorporated · highest

85
Nalux · near

41
Centro DE INGENIERÍA… · this assignee

41
GreenLight Biosciences · near

41
THE Antenna… · near

41
BackBeat Medical · near

41
3D Lighting… · lowest

7

What this shows Centro's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Centro?

Each dot is one of Centro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Centro’s own 9.8 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Centro vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Centro's grants concentrate

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA is a focused PatentsView assignee: 22 CPC subclasses with 79.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (10 grants) versus a trough of 1 in 2020. By volume, Centro sits between Bedford Systems LLC and Catalina Marketing Corporation.

Centro's three-year grant acceleration

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bedford Systems

39
Biomed Valley Dis…

39
Brose Fahrzeugtei…

39
Caci —Federal

39
Cynosure

39
Can't Live Withou…

39
Capbran Holdings

39
Catalina Marketing

39
Centro DE Ingenie… ◀

39

What this shows Centro holds 39 patents at rank #8,174, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Centro

By rank, the assignees closest to #8,174 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Centro's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Centro, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Centro ranks #634 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

THE Antenna Company International N.V. 41 GreenLight Biosciences, Inc. 41 BackBeat Medical, LLC 41 Nalux Co., Ltd. 41

Centro's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	25.6%
2016	7	17.9%
2017	5	12.8%
2018	3	7.7%
2019	2	5.1%
2020	1	2.6%
2021	4	10.3%
2022	2	5.1%
2023	2	5.1%
2024	2	5.1%
2025partial year	1	2.6%

Which technologies does Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 31

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 31

C07K - Peptides 19

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

A23K - Fodder 5

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 4

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C12Y - Enzymes 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

C07D - Heterocyclic Compounds 2

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's patent record in context - here's where to go next.

Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 79.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,179 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Centro DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA against Bedford Systems LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.